Literature DB >> 28704200

Mild cognitive impairment in type 2 diabetes mellitus and related risk factors: a review.

Xiao-Ying Yuan1, Xu-Gang Wang1.   

Abstract

Type 2 diabetes mellitus (T2DM) is a global epidemic disease and has become a significant health problem. Many studies have raised concern about the mild cognitive impairment (MCI) with T2DM and even the Alzheimer's disease patients with T2DM. The incidence of MCI is higher in individuals with T2DM than those without diabetes. Cognitive changes might affect everyday activities depending on the work and situation. Although the exact pathophysiology of MCI in T2DM is unclear, many studies suggest that the alterations in pathoglycemia, diabetic complications, related end products, and physical/psychological status are significant risk factors. In this article, we systematically overview the studies to illustrate the related risk factors of cognitive impairment in patients with T2DM. Further high quality studies and treatment need to be initiated and it will become incumbent on clinicians to identify and cure the earliest signs of clinical impairment.

Entities:  

Keywords:  Alzheimer’s disease (AD); mild cognitive impairment (MCI); risk factor; type 2 diabetes mellitus (T2DM)

Mesh:

Year:  2017        PMID: 28704200     DOI: 10.1515/revneuro-2017-0016

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  22 in total

1.  Expert Consensus on Cognitive Dysfunction in Diabetes.

Authors:  Yan Yang; Jia-Jun Zhao; Xue-Feng Yu
Journal:  Curr Med Sci       Date:  2022-03-15

2.  Association between Blood Glucose Control and Subjective Cognitive Decline in Korean Patients with Diabetes Aged over 50 Years.

Authors:  Dae-Hyung Koh; Yu-Jin Rho; Soon Young Lee; Kyoung-Nam Kim; Yeong Jun Ju
Journal:  Int J Environ Res Public Health       Date:  2022-06-14       Impact factor: 4.614

3.  Type 2 Diabetes Mellitus Is Associated with the Risk of Cognitive Impairment: a Meta-Analysis.

Authors:  Xiaojun Zhang; Xiaolu Jiang; Sufang Han; Qianqi Liu; Jing Zhou
Journal:  J Mol Neurosci       Date:  2019-04-04       Impact factor: 3.444

4.  Associations between coronary heart disease and risk of cognitive impairment: A meta-analysis.

Authors:  Xuan Liang; Yilin Huang; Xu Han
Journal:  Brain Behav       Date:  2021-03-20       Impact factor: 2.708

5.  Plasma microRNAs biomarkers in mild cognitive impairment among patients with type 2 diabetes mellitus.

Authors:  Iman I Salama; Samia M Sami; Ghada A Abdellatif; Amira Mohsen; Hanaa Rasmy; Solaf Ahmed Kamel; Mona Hamed Ibrahim; Mona Mostafa; Walaa A Fouad; Hala M Raslan
Journal:  PLoS One       Date:  2020-07-29       Impact factor: 3.240

6.  Tau underlies synaptic and cognitive deficits for type 1, but not type 2 diabetes mouse models.

Authors:  Laura Trujillo-Estrada; Cassidy Nguyen; Celia da Cunha; Lena Cai; Stefania Forner; Alessandra C Martini; Rahasson R Ager; Gilberto Aleph Prieto; Carl W Cotman; David Baglietto-Vargas; Frank M LaFerla
Journal:  Aging Cell       Date:  2019-02-27       Impact factor: 9.304

7.  The factors contributing to cognitive dysfunction in type 2 diabetic patients.

Authors:  San-Shan Xia; Wen-Lin Xia; Jiao-Jiao Huang; Hua-Jie Zou; Jing Tao; Yan Yang
Journal:  Ann Transl Med       Date:  2020-02

8.  Brain-derived neurotrophic factor Val66Met polymorphism is associated with mild cognitive impairment in elderly patients with type 2 diabetes: a case-controlled study.

Authors:  Jia Liu; Wei Yang; Hongyu Luo; Yixin Ma; Huan Zhao; Xiaojuan Dan
Journal:  Aging Clin Exp Res       Date:  2020-09-06       Impact factor: 3.636

9.  Neuritin inhibits astrogliosis to ameliorate diabetic cognitive dysfunction.

Authors:  Zuo Zhang; Hongli Zhou; Jiyin Zhou
Journal:  J Mol Endocrinol       Date:  2021-04       Impact factor: 5.098

10.  Exercise or physical activity and cognitive function in adults with type 2 diabetes, insulin resistance or impaired glucose tolerance: a systematic review.

Authors:  Ren Ru Zhao; Anthony J O'Sullivan; Maria A Fiatarone Singh
Journal:  Eur Rev Aging Phys Act       Date:  2018-01-22       Impact factor: 3.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.